4N. Paul Ohori, Edward L. Santa Maria. Cytopathologic Diagnosis of Bronchioloalveolar Carcinoma. Am J Clin Pathol, 2004,122 : 44 - 50.
5Kitazaki T, Fukuda M, Soda H, Kohno S. Novel effects of gefitinib on mucin production in bronchioloalveolar carcinoma;two case reports.Lung Cancer 2005,49:125 - 128.
6Mark G. Kris, Giuseppe Giaccone, Angela Davies, et al. Systemic Therapy of Bronchioloalveolar Carcinoma: Results of the First IASLC/ASCO Consensus Conference on Bronchioloalveolar Carcinoma. J Thorac Oncol,2006,1:32 - 36.
7David R, Gandara, Howard West, Karl Chansky, et al. Bronchioloalveolar Carcinoma:A Model for Investigating the Biology of Epidermal Growth Factor Receptor Inhibition. Clin Cancer Res ,2004 (Suppl ), 10:4205 - 4209.
8Y ano S, Kanematsu T, Miki T, et al. A report of two bronchioloalveolar carcinoma cases which were rapidly improved by treatment with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 ( "Iressa" (1). Cancer Sci ,2003,94:453 -458.
9David C. Christiani, William Pao, James C. DeMartini, et al. BAC Consensus Conference, November 4 - 6,2004 : Epidemiology, Pathogenesis, and Preclinical Models. J Thorac Oncol. 2006,1 :S2 -S7.
